Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 9, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

Lactoferrin-Templated Silver Peroxide Nanoparticles Reinforced Core-Shell Microneedle for Diabetic Infected Wound

Jianying Hao1, Xiang Ji1, Xiuqiang Li1

  • 1School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.

Small (Weinheim an Der Bergstrasse, Germany)
|July 8, 2026
PubMed
Summary

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization and expression analysis of UBC gene family provide insights into the potential roles in pigment biosynthesis in pepper fruit.

BMC genomics·2026
Same author

Performance and mechanisms of a biochar-enhanced partial nitritation/anammox process for the treatment of silane tower wastewater.

Bioresource technology·2026
Same author

Deciphering the Transcription Factor-Dominated Ecosystem During Esophageal Squamous Cell Carcinoma Progression at the Single-Cell Level.

International journal of molecular sciences·2026
Same author

Uncovering the Key Circuit FOSL2/FOS/EGR3/EGR1, Contributing to the Hyperexcitability of Excitatory Neurons in the Epileptic Temporal Cortex and Hippocampus.

International journal of molecular sciences·2026
Same author

Coordinated Multicellular Immune Programs and Drug Targets Revealed by Single-Cell Analysis in Driver-Mutated NSCLC.

International journal of molecular sciences·2026
Same author

<i>Streptococcus suis</i> autolysin functions as a molecular bridge for epithelial adhesion via lipoteichoic acid interaction.

Infection and immunity·2026
This summary is machine-generated.

This study presents novel lactoferrin-silver oxide nanoparticles (LF-Ag2O2 NPs) and a microneedle patch for enhanced diabetic wound healing. The system delivers sequential antibacterial and regenerative treatments, improving healing outcomes.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Regenerative Medicine

Background:

  • Diabetic wounds present significant healing challenges due to infection and inflammation.
  • Existing nanosilver antibacterial agents face limitations in preparation, stability, and biocompatibility.

Purpose of the Study:

  • To develop improved lactoferrin-silver oxide nanoparticles (LF-Ag2O2 NPs) for enhanced antibacterial activity.
  • To create a core-shell microneedle patch for programmed sequential delivery of LF-Ag2O2 NPs and fibroblast growth factor (FGF) for diabetic wound treatment.

Main Methods:

  • Synthesized LF-Ag2O2 NPs using a one-step biomimetic mineralization method with lactoferrin (LF) as a dispersant.
  • Designed a core-shell microneedle patch with a layered drug loading strategy for controlled release.
Keywords:
LF‐Ag2O2 nanoparticlesantibacterial effectcore–shell microneedlediabetic wound healingsequential therapy

Related Experiment Videos

Last Updated: Jul 9, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

  • Investigated the synergistic antibacterial effects and the regenerative potential of the microneedle patch in a diabetic wound model.
  • Main Results:

    • LF-Ag2O2 NPs exhibited improved dispersibility, stability, and biocompatibility compared to traditional agents.
    • The microneedle patch demonstrated rapid release of LF-Ag2O2 NPs for bacterial elimination and subsequent slow release of FGF for tissue regeneration.
    • The system effectively disrupted the infection-inflammation cycle and accelerated diabetic wound healing.

    Conclusions:

    • The developed LF-Ag2O2 NPs and microneedle patch offer a promising strategy for managing complex diabetic wounds.
    • This programmed drug delivery system enhances wound healing by combining antibacterial and regenerative therapeutic actions.